Clinical Evidence

Delve into clinical research studies and more 

Clinical research lies at the heart of who we are. Vantive uses scientific evidence systematically and transparently, to inform the development of state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Vantive.

254 results

HDx therapy enabled by Theranova
Evaluation of the influence of the surface membrane and blood flow in medium «cut-off» (MCO) dialyzers
Visit resource site
HDx therapy enabled by Theranova
Evaluation of VIE-X Filter Performances vs. Medium Cut-Off Dialyzer and High-Flux Dialyzers on Protein Loss and Inflammatory Status of Chronic Hemodialysis Patients
Visit resource site
HDx therapy enabled by Theranova
Expanded dialysis (HDx): is there an impact on patient reported symptoms?
Visit resource site
HDx therapy enabled by Theranova
Expanded Dialysis With Theranova Compared to Conventional High-Flux Hemodialysis: A Randomized Prospective 12-Month Study
Visit resource site
HDx therapy enabled by Theranova
Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins
Visit resource site
HDx therapy enabled by Theranova
Expanded Haemodialysis Therapy of Chronic Haemodialysis Patients Prevents Calcification and Apoptosis of Vascular Smooth Muscle Cells in vitro
Visit resource site
HDx therapy enabled by Theranova
Expanded Haemodialysis Therapy of Chronic Haemodialysis Patients Prevents Calcification and Apoptosis of Vascular Smooth Muscle Cells in vitro
Visit resource site
HDx therapy enabled by Theranova
Expanded haemodialysis: from operational mechanism to clinical results
Visit resource site
HDx therapy enabled by Theranova
Expanded haemodialysis: news from the field
Visit resource site
HDx therapy enabled by Theranova
Expanded Hemodialysis - A step closer to natural kidneys
Visit resource site
HDx therapy enabled by Theranova
Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism
Visit resource site
HDx therapy enabled by Theranova
Expanded Hemodialysis and Its Effects on Hospitalizations and Medication Usage: A Cohort Study.
Visit resource site

Vantive is a trademark of Vantive Health LLC or its affiliates.